{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:45:55Z","timestamp":1792658755032,"version":"4.5.0"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3,1]]},"DOI":"10.1097\/qai.0b013e318209751e","type":"journal-article","created":{"date-parts":[[2011,2,11]],"date-time":"2011-02-11T03:03:23Z","timestamp":1297393403000},"page":"S22-S32","source":"Crossref","is-referenced-by-count":221,"title":["HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine\/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study"],"prefix":"10.1097","volume":"56","author":[{"given":"Frederick L","family":"Altice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Douglas","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula J","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P Todd","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P","family":"Flanigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinazo O","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn E","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Vergara-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adan","family":"Cajina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Botsko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc N","family":"Gourevitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Finkelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(10)60829-X","article-title":"Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.","volume":"376","author":"Altice","year":"2010","journal-title":"Lancet"},{"key":"R2-5-20210131","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJM198112103052402","article-title":"An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction.","volume":"305","author":"Masur","year":"1981","journal-title":"N Engl J Med"},{"key":"R3-5-20210131","first-page":"28","article-title":"Buprenorphine and the treatment of opioid addiction.","volume":"9","author":"Stancliff","year":"2004","journal-title":"The PRN Notebook"},{"key":"R5-5-20210131","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMcp013579","article-title":"Clinical practice. Office-based treatment of opioid-dependent patients.","volume":"347","author":"Fiellin","year":"2002","journal-title":"N Engl J Med"},{"key":"R6-5-20210131","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0740-5472(02)00259-3","article-title":"History and current status of opioid maintenance treatments: blending conference session.","volume":"23","author":"Kreek","year":"2002","journal-title":"J Subst Abuse Treat"},{"key":"R8-5-20210131","first-page":"329","article-title":"Advancing HIV prevention: new strategies for a changing epidemic--United States, 2003.","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R9-5-20210131","first-page":"634","article-title":"HIV diagnoses among injection-drug users in states with HIV Surveillance--25 states, 1994-2000.","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R10-5-20210131","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.qai.0000159666.95455.d2","article-title":"HIV drug resistance and HIV transmission risk behaviors among active injection drug users.","volume":"40","author":"Kozal","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 2","key":"R11-5-20210131","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/01.qai.0000140605.51640.5c","article-title":"Clinician-initiated HIV risk reduction intervention for HIV-positive persons: formative research, acceptability, and fidelity of the Options Project.","volume":"37","author":"Fisher","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R12-5-20210131","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2471\/BLT.09.067330","article-title":"Preventing HIV transmission with antiretrovirals.","volume":"87","author":"De Cock","year":"2009","journal-title":"Bull World Health Organ"},{"key":"R13-5-20210131","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","article-title":"Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.","volume":"373","author":"Granich","year":"2009","journal-title":"Lancet"},{"issue":"Suppl 3","key":"R14-5-20210131","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1097\/00126334-200212153-00014","article-title":"Interventions to improve adherence to antiretroviral therapy.","volume":"31","author":"Tuldra","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-5-20210131","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.","volume":"4","author":"Mattick","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"R16-5-20210131","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1300\/J069v20n02_03","article-title":"Report of the Council on Scientific Affairs: methadone maintenance and needle-exchange programs to reduce the medical and public health consequences of drug abuse.","volume":"20","author":"Yoast","year":"2001","journal-title":"J Addict Dis"},{"key":"R17-5-20210131","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1081\/ADA-120002972","article-title":"Treatment of heroin dependence with buprenorphine in primary care.","volume":"28","author":"Fiellin","year":"2002","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R18-5-20210131","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.","volume":"343","author":"Johnson","year":"2000","journal-title":"N Engl J Med"},{"key":"R19-5-20210131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0376-8716(95)01186-2","article-title":"A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence.","volume":"40","author":"Johnson","year":"1995","journal-title":"Drug Alcohol Depend"},{"key":"R20-5-20210131","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1176\/appi.ajp.158.8.1200","article-title":"Office-based treatment for opioid dependence: reaching new patient populations.","volume":"158","author":"Fiellin","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R21-5-20210131","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/00952999108992815","article-title":"Treatment of heroin addicts using buprenorphine.","volume":"17","author":"Kosten","year":"1991","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R22-5-20210131","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jsat.2004.06.005","article-title":"Consensus statement on office-based treatment of opioid dependence using buprenorphine.","volume":"27","author":"Fiellin","year":"2004","journal-title":"J Subst Abuse Treat"},{"issue":"Suppl 4","key":"R23-5-20210131","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1086\/508181","article-title":"The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention.","volume":"43","author":"Altice","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R24-5-20210131","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1590\/S0102-311X2006000400019","article-title":"Utilization of HIV\/AIDS treatment services: comparing injecting drug users and other clients.","volume":"22","author":"Melo","year":"2006","journal-title":"Cad Saude Publica"},{"key":"R25-5-20210131","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.idc.2007.03.009","article-title":"Clinical care of the HIV-infected drug user.","volume":"21","author":"Bruce","year":"2007","journal-title":"Infect Dis Clin North Am"},{"key":"R26-5-20210131","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.","volume":"343","author":"Johnson","year":"2000","journal-title":"N Engl J Med"},{"key":"R27-5-20210131","doi-asserted-by":"crossref","first-page":"704","DOI":"10.7326\/0003-4819-152-11-201006010-00003","article-title":"Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: a randomized trial.","volume":"152","author":"Lucas","year":"2010","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"R28-5-20210131","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/QAI.0b013e318209740f","article-title":"A model federal collaborative to increase patient access to buprenorphine treatment in HIV primary care.","volume":"56","author":"Cheever","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R30-5-20210131","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.","volume":"168","author":"McLellan","year":"1980","journal-title":"J Nerv Ment Dis"},{"key":"R31-5-20210131","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index.","volume":"9","author":"McLellan","year":"1992","journal-title":"J Subst Abuse Treat"},{"key":"R32-5-20210131","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/A:1018460132567","article-title":"Applications of the Medical Outcomes Study health-related quality of life measures in HIV\/AIDS.","volume":"6","author":"Wu","year":"1997","journal-title":"Qual Life Res"},{"key":"R33-5-20210131","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1080\/09540120802657555","article-title":"Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy.","volume":"21","author":"Springer","year":"2009","journal-title":"AIDS Care"},{"key":"R34-5-20210131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0740-5472(99)00025-2","article-title":"The Addiction Severity Index: a field study of internal consistency and validity.","volume":"18","author":"Leonhard","year":"2000","journal-title":"J Subst Abuse Treat"},{"key":"R35-5-20210131","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R36-5-20210131","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0140-6736(10)60932-4","article-title":"High, CD4 Count in Antiretroviral Naive Patients, Lodwick RK, Sabin CA, et al. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"R37-5-20210131","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/QAI.0b013e3181e66216","article-title":"Inflammation and mortality in HIV-infected adults: analysis of the FRAM Study Cohort.","volume":"55","author":"Tien","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R38-5-20210131","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1086\/506362","article-title":"Rates of disease progression according to initial highly active antiretroviral therapy regimen: a collaborative analysis of 12 prospective cohort studies.","volume":"194","year":"2006","journal-title":"J Infect Dis"},{"key":"R39-5-20210131","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/QAD.0b013e3282f7cb76","article-title":"CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.","volume":"22","author":"Baker","year":"2008","journal-title":"AIDS"},{"key":"R40-5-20210131","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/630209","article-title":"Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.","volume":"49","author":"Roux","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"Suppl","key":"R41-5-20210131","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10461-007-9246-3","article-title":"The effects of housing status on health-related outcomes in people living with HIV: a systematic review of the literature.","volume":"11","author":"Leaver","year":"2007","journal-title":"AIDS Behav"},{"issue":"Suppl","key":"R42-5-20210131","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10461-007-9276-x","article-title":"Housing need, housing assistance, and connection to HIV medical care.","volume":"11","author":"Aidala","year":"2007","journal-title":"AIDS Behav"},{"key":"R43-5-20210131","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.2105\/AJPH.2006.090209","article-title":"Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV\/AIDS.","volume":"97","author":"Kidder","year":"2007","journal-title":"Am J Public Health"},{"key":"R44-5-20210131","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/09540120410001683411","article-title":"Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users.","volume":"16","author":"Loughlin","year":"2004","journal-title":"AIDS Care"},{"key":"R45-5-20210131","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1086\/521250","article-title":"Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis.","volume":"45","author":"Petersen","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R46-5-20210131","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/09540120802270250","article-title":"Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV.","volume":"21","author":"Royal","year":"2009","journal-title":"AIDS Care"},{"key":"R47-5-20210131","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.drugalcdep.2010.06.014","article-title":"A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization.","volume":"112","author":"Azar","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"R48-5-20210131","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/QAI.0b013e31815ace7e","article-title":"The influence of psychosocial characteristics and race\/ethnicity on the use, duration, and success of antiretroviral therapy.","volume":"47","author":"Pence","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R49-5-20210131","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1080\/09540120701294245","article-title":"Factors associated with discontinuation of antiretroviral therapy in HIV-infected patients with alcohol problems.","volume":"19","author":"Kim","year":"2007","journal-title":"AIDS Care"},{"key":"R50-5-20210131","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QAI.0b013e3181900129","article-title":"Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users.","volume":"50","author":"Baum","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R51-5-20210131","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00002030-200203290-00012","article-title":"Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.","volume":"16","author":"Lucas","year":"2002","journal-title":"AIDS"},{"key":"R52-5-20210131","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/archinte.165.9.986","article-title":"Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis.","volume":"165","author":"Bertholet","year":"2005","journal-title":"Arch Intern Med"},{"key":"R53-5-20210131","first-page":"CD004147","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence.","volume":"4","author":"Amato","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R54-5-20210131","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1258\/ijsa.2007.007093","article-title":"Influence of antiretroviral treatment on quality of life in seropositive inmates.","volume":"19","author":"del Castillo","year":"2008","journal-title":"Int J STD AIDS"},{"key":"R55-5-20210131","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/0954012031000134818","article-title":"Determinants of health-related quality of life in HIV-infected patients.","volume":"15","author":"Murri","year":"2003","journal-title":"AIDS Care"},{"key":"R56-5-20210131","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/09540120412331305098","article-title":"Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence.","volume":"17","author":"Mannheimer","year":"2005","journal-title":"AIDS Care"},{"key":"R57-5-20210131","first-page":"1213","article-title":"Neurocognitive Impairment and HIV risk factors: a reciprocal relationship AIDS Behav.","volume":"14","author":"Anand","year":"2010","journal-title":""},{"issue":"Suppl 1","key":"R58-5-20210131","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/QAI.0b013e318209754c","article-title":"Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics.","volume":"56","author":"Korthius","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R59-5-20210131","doi-asserted-by":"crossref","first-page":"e2783","DOI":"10.1371\/journal.pone.0002783","article-title":"Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels.","volume":"3","author":"Parienti","year":"2008","journal-title":"PLoS One"},{"key":"R60-5-20210131","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/QAD.0b013e32832ba8ec","article-title":"Antiretroviral medication adherence and the development of class-specific antiretroviral resistance.","volume":"23","author":"Gardner","year":"2009","journal-title":"AIDS"},{"key":"R61-5-20210131","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/QAI.0b013e31819675e9","article-title":"The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time.","volume":"50","author":"Lima","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R62-5-20210131","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.","volume":"360","author":"Egger","year":"2002","journal-title":"Lancet"},{"key":"R63-5-20210131","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1086\/432883","article-title":"Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.","volume":"41","author":"Kohli","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R64-5-20210131","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/QAI.0b013e318198a800","article-title":"Nonstructured treatment interruptions among injection drug users in Baltimore, MD.","volume":"50","author":"Kavasery","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R65-5-20210131","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/10872910151133701","article-title":"An investigation of why eligible patients do not receive HAART.","volume":"15","author":"Maisels","year":"2001","journal-title":"AIDS Patient Care STDs"},{"key":"R66-5-20210131","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003495-200666060-00004","article-title":"Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.","volume":"66","author":"Chander","year":"2006","journal-title":"Drugs"},{"key":"R67-5-20210131","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1525-1497.2004.30429.x","article-title":"Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patients.","volume":"19","author":"Wong","year":"2004","journal-title":"J Gen Intern Med"},{"key":"R68-5-20210131","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/108729103321619782","article-title":"Adherence to HIV antiretrovirals among persons with serious mental illness.","volume":"17","author":"Wagner","year":"2003","journal-title":"AIDS Patient Care STDs"},{"key":"R69-5-20210131","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/09540120802001705","article-title":"Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders.","volume":"21","author":"Mellins","year":"2009","journal-title":"AIDS Care"},{"key":"R70-5-20210131","first-page":"378","article-title":"Editorial comment: why treat three conditions when it is one patient?","volume":"13","author":"Bruce","year":"2003","journal-title":"AIDS Read"},{"issue":"Suppl 1","key":"R71-5-20210131","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/QAI.0b013e31820a8226","article-title":"Integration of buprenorphine\/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative.","volume":"56","author":"Weiss","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R72-5-20210131","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1086\/500200","article-title":"Models for integrating buprenorphine therapy into the primary HIV care setting.","volume":"42","author":"Basu","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e318209751e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:45:04Z","timestamp":1786041904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201103011-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":69,"journal-issue":{"issue":"Supplement 1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318209751e","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,1]]}}}